Apollo Hospital Enterprises

Stocks to watch on November 7, 2024: Apollo Hospitals Enterprise reported Q2FY25 net profit of Rs 380 crore, up from Rs 233 crore Y-o-Y

Shares of Apollo Hospitals hit a lifetime high at Rs 7,435.40 per share on the BSE, zooming 6.67 per cent in Thursday's intraday deals

Shares of Apollo Hospitals Enterprise (AHEL) rose 2.92 per cent to Rs 6,711.95 per share on the BSE in Friday's early morning trade

The markets traded lackluster and ended slightly lower, continuing the ongoing consolidation phase. After a flat start, the Nifty fluctuated within a narrow range, eventually closing at 24,413.50.

On an hourly scale, MRPL has been showing a consolidation pattern above the 21, 50, 100, and 200-period Exponential Moving Averages (EMA)

They are on an expansion spree and guided for more bed additions in FY25

By 2025, cancer cases projected to hit 1.57 million, up 13% from 2020

Funds are to be utilised for growth capital in AHL, to pay for the Rs 890 cr of the Rs 1290 cr slump sale consideration owed to AHEL, and acquisition of an 11.2 per cent stake in Keimed for Rs 730 cr

Apollo Hospitals Enterprises stock update: The stock hit its lowest level since January 10, 2024

Advent and Apollo HealthCo have entered into a deal through which Advent will invest Rs 2,475 crore into Apollo HealthCo

Sasidhar, the new president and chief executive officer of Apollo's hospital division, talks about future expansion, medical tourism, and growth roadmap

A latest report on the health scenario in India on Friday indicated a significant growth in non-communicable diseases (NCDs) across the nation and said the country was witnessing fastest rise in cancer cases. On average, atleast one in three Indians today were pre-diabetic, two in three were pre-hypertensive and one in 10 were depressed, the 4th edition of Apollo Hospitals' flagship Health of Nation Report on World Health Day 2024, said. The report sheds light on the concerning rise of NCDs in India, including cancer, diabetes, hypertension, cardiovascular diseases, and mental health issues, all of which significantly impact the nation's overall health, the hospital said in a release here. Particularly alarming was the escalating incidence of cancer in India compared to global rates, making India the "cancer capital of the world," it said. The annual report predicted a potential surge in healthcare burdens due to conditions such as pre-diabetes, pre-hypertension, and mental health

Traditional brain surgeries last three to four hours, ZAP-X completes treatment within a single session lasting no more than 30 minutes, John R Adler, founder and CEO of Zap Surgical said

Barring Dr Lal Pathlabs, the other four healthcare related stocks listed below seem to be trapped in a range for now, charts suggest.

According to the Telegraph report, poor people from Myanmar "are being flown" to the Indraprastha Apollo Hospital in Delhi to sell "their kidneys to rich Burmese patients"

Apollo Hospitals Enterprise Ltd has recorded a standalone profit after tax of Rs 294.8 crore for the three months ended September 30, 2023, the healthcare major said on Friday. Apollo Hospitals reported a standalone profit after tax of Rs 279.1 crore during the corresponding quarter last year. For the half-year period ended September 30, 2023, the standalone profit after tax stood at Rs 508.9 crore, as against Rs 612.3 crore registered in the same period last year, the company said on Friday. Total income on a standalone basis during the quarter under review grew to Rs 1,931.1 crore from Rs 1,758.5 crore during the corresponding quarter of the previous year. For the six-month period ended September 30, 2023, the standalone total income grew to Rs 3,637.3 crore against Rs 3,298.7 crore registered in the same period last year. In a statement, Apollo Hospitals said the board, based on the recommendations of the investment committee, has evaluated and approved an expansion plan for th

In May, Apollo's fourth-quarter revenue from healthcare services climbed 18.5% and accounted for 51% of its total revenue

Stocks to watch on May 31, 2023: From Adani Ports to Sun Pharma, here are top stocks to watch in Wednesday's trading session

The company's consolidated revenue from operation rose by 21.3 per cent to Rs 4,302 crore for the March quarter as compared to Rs 3,546 crore in the year-ago period

Stocks to Watch Today: In the F&O space, BHEL, Delta Corp, Indiabulls Housing Finance and PNB are the stocks in ban period on Thursday.